Cargando…
SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma
BACKGROUND: SDHD promoter mutations were reported in 4–10% of cutaneous melanomas. The advanced clinico-pathological and patient survival association with SDHD mutation and/or expression in cutaneous melanoma remains controversial. OBJECTIVES: To evaluate the presence of SDHD promoter mutations and...
Autores principales: | Pópulo, Helena, Batista, Rui, Sampaio, Cristina, Pardal, Joana, Lopes, José Manuel, Soares, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491217/ https://www.ncbi.nlm.nih.gov/pubmed/28662141 http://dx.doi.org/10.1371/journal.pone.0180392 |
Ejemplares similares
-
Analysis of SDHD promoter mutations in various types of melanoma
por: Scholz, Simone L., et al.
Publicado: (2015) -
Sdhd and Sdhd/H19 Knockout Mice Do Not Develop Paraganglioma or Pheochromocytoma
por: Bayley, Jean-Pierre, et al.
Publicado: (2009) -
No evidence for involvement of SDHD in neuroblastoma pathogenesis
por: De Preter, Katleen, et al.
Publicado: (2004) -
Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations
por: Bayley, Jean-Pierre, et al.
Publicado: (2014) -
Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients
por: Huang, Yiqiang, et al.
Publicado: (2018)